Novartis AG (Novartis AG) Price-to-Operating-Cash-Flow

: 13.64 (As of Today)

View and export this data going back to 1996. Start your Free Trial

As of today (2024-04-16), Novartis AG's share price is $94.41. Novartis AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $6.92. Hence, Novartis AG's Price-to-Operating-Cash-Flow Ratio for today is 13.64.

The historical rank and industry rank for Novartis AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

NVS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.5 Med: 13.16 Max: 16.3
Current: 13.9

During the past 13 years, Novartis AG's highest Price-to-Operating-Cash-Flow Ratio was 16.30. The lowest was 10.50. And the median was 13.16.

NVS's Price-to-Operating-Cash-Flow is ranked better than
57.9% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.25 vs NVS: 13.90

Novartis AG's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.23. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $6.92.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novartis AG was -1.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.30% per year.

During the past 13 years, Novartis AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 13.90% per year. The lowest was -7.10% per year. And the median was 4.20% per year.

Novartis AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Novartis AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

15.09

15.01

12.39

13.12

14.20

Novartis AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																13.12	11.64	12.71	12.83	14.20

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novartis AG's Price-to-Operating-Cash-Flow falls into.

Novartis AG Price-to-Operating-Cash-Flow Calculation

Novartis AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	94.41	/	6.922
	=	13.64

Novartis AG's Share Price of today is $94.41.
Novartis AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.92.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Novartis AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Novartis AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.